Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T08:21:20.520Z Has data issue: false hasContentIssue false

Clozapine use in old age psychiatry

Published online by Cambridge University Press:  25 April 2018

Rights & Permissions [Opens in a new window]

Summary

Clozapine is one of the most effective drugs available to psychiatrists for treating psychosis. It is currently licensed for use in treatment-resistant schizophrenia and psychosis in Parkinson's disease, but its use in old age psychiatry is very uncommon. With the ageing population, and the increased incidence of psychosis in older patients, it is important to consider whether this is a drug that is not being used to its full advantage.

LEARNING OBJECTIVES

  • • Appreciate the differences in titration and monitoring of clozapine in older adults, compared with working-age adults

  • • Consider the efficacy of clozapine in older people and its impact on mortality

  • • Understand the side-effect profile of clozapine in older adults

DECLARATION OF INTEREST

None.

Information

Type
Articles
Copyright
Copyright © The Royal College of Psychiatrists 2018 
Figure 0

TABLE 1Clozapine prescribing for treatment-resistant schizophrenia and Parkinson's disease in older adults (>65 years of age)

Figure 1

TABLE 2STOPP/START examples of medication review in older adults (>65 years of age)

Figure 2

TABLE 3Receptor profile of clozapine and related side-effects

Figure 3

TABLE 4Frequency of commonly reported side-effects of clozapine (18–65 years)

Submit a response

eLetters

No eLetters have been published for this article.